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Bradley Worley and Robert Powers*
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Abstract
Metabolomics aims to provide a global snapshot of all small-molecule metabolites in cells and 
biological fluids, free of observational biases inherent to more focused studies of metabolism. 
However, the staggeringly high information content of such global analyses introduces a challenge 
of its own; efficiently forming biologically relevant conclusions from any given metabolomics 
dataset indeed requires specialized forms of data analysis. One approach to finding meaning in 
metabolomics datasets involves multivariate analysis (MVA) methods such as principal 
component analysis (PCA) and partial least squares projection to latent structures (PLS), where 
spectral features contributing most to variation or separation are identified for further analysis. 
However, as with any mathematical treatment, these methods are not a panacea; this review 
discusses the use of multivariate analysis for metabolomics, as well as common pitfalls and 
misconceptions.
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Introduction
Metabolomics is defined [1] as “the quantitative measurement of the multiparametric 
metabolic response of living systems to pathophysiological stimuli or genetic modification.” 
Such a definition implies that metabolomic studies offer the finest-grained detail available in 
the nascent field of systems biology: a molecular-level convolution of all upstream genomic, 
transcriptomic and proteomic responses of an organism to a given stimulus or change [2-4]. 
Metabolites are the end product of all cellular processes, and are a direct outcome of 
enzymatic and protein activity. Thus, metabolites are more proximal to a phenotype or 
disease than either genetic or proteomic information [5, 6]. This occurs because a simple 
change in the expression level of a gene or protein does not necessarily correlate directly 
with a variation in the activity level of a protein, but an alteration in a metabolite only occurs 
through such a change [7]. Consequently, metabolomics has been used to identify disease 
biomarkers [8, 9], to aid in the drug discovery process [10, 11], and to study plants [12], 
bacteria [13, 14], nutrition [15], and the environment [16], among numerous other 
applications [17].
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However, metabolomics experiments are plagued with difficulty. The number of small-
molecule metabolites in a biofluid, cell lysate, tissues or organ differs wildly depending on 
the organism studied, ranging from several hundred to hundreds of thousands [18]. 
Metabolomics is also a relatively new discipline and as a result a complete catalog of the 
human metabolome and the metabolomes of other organisms is not available [19]. 
Therefore, it is common to encounter unknown metabolites, a complication in the analysis 
and interpretation of metabolic changes. Similarly, the lack of reference NMR or MS spectra 
for all known metabolites makes proper identification of metabolites challenging [20-22]. 
Further, the exhibited diversity of chemical and physical properties of compounds within the 
metabolome makes true metabolomics (simultaneous quantification of all metabolites) 
unattainable with current instrumental capabilities [1, 18, 23]. As an illustration, the limited 
molecular-weight distribution of the metabolome prohibits a comprehensive and detailed 
analysis by mass spectroscopy and generally requires the additional use of chromatography 
[2, 24].
The analysis of metabolomic data is further complicated by the inherent variability in each 
sample. Every single cell, tissue, organ or organism is fundamentally unique [25], despite 
any defining feature they share in common, such as being the same species, infected with the 
same disease or receiving the same drug treatment. As such, the overall goal of 
metabolomics is to identify the few chemical features against a large and complex 
background of metabolites that uniquely define the system [20, 26]. These few chemical 
features or metabolites should be directly related to the defining characteristic of the system. 
But, unfortunately, all biological systems are easily perturbed by any number of 
experimental or environmental factors, such as age, diet, growth phase, media, nutrients, pH, 
sex, and temperature [27, 28]. Similarly, cell lysis, enzyme quenching and metabolome 
extraction techniques, and the storage of the metabolomics samples can also induce 
undesirable variations. There are also unavoidable fluctuations in spectral data, such as 
changes in peak position or peak width that are caused by instrument instability and 
variability in sample conditions. As a result, the analysis of metabolomic data requires a 
robust methodology to expose underlying trends in these highly complex and variable data 
sets.
One class of methods, appropriately termed “metabolic fingerprinting,” aims to retain much 
of the promised unbiased, global nature of the metabolomics experiment by differentially 
analyzing spectral information acquired from normal and perturbed systems [29]. Again, a 
perturbed system may result from a disease state, a drug treatment, the presence of a pest or 
parasite, an environmental stimulus (pH, temperature, toxin, or nutrient change), a temporal, 
spatial, or species difference. Metabolic fingerprinting is also amenable to high throughput 
data collection and analysis, since global metabolite profiling can be accomplished with 
minimal samples and rapid spectral acquisitions [30]. The goal of metabolic fingerprinting 
experiments is to determine the relative differences between the metabolomes of two or 
more systems to infer a biological relationship. Thus, a hallmark of metabolic fingerprinting 
is the use of multivariate analysis methods to identify those biologically relevant spectral 
features for further targeted analyses [1, 23, 31], with two of the most popular methods 
being principal component analysis (PCA) [32, 33] and partial least squares projection to 
latent structures (PLS) [34, 35]. In essence, PCA and PLS aim to differentiate between 
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classes in highly complex data sets, despite within class variability. These multivariate 
analysis methods will be briefly described, along with a discussion of their application to 
metabolomics, with an emphasis on common errors and misconceptions.
Metabolomics datasets
The choice of analytical method used for metabolic fingerprinting experiments is limited 
primarily by its ability to reveal metabolic differences due to system perturbations. Other 
desirable features include minimal sample preparations or requirements, and the ability to 
analyze the samples in a high-throughput manner. High-resolution 1H NMR spectroscopy is 
especially suited for probing biofluids, cell lysates and tissues with almost no sample 
treatment and without bias [36, 37]. Mass spectrometry is similarly employed for metabolic 
fingerprinting and is typically favored for its sensitivity in more global metabolic profiling 
applications, but generally requires upstream chromatographic separations due to the limited 
molecular-weight diversity of metabolites [37-39]. Raman and Fourier-transform infrared 
(FT-IR) spectroscopies have also been successfully utilized [31, 40] for metabolomic 
studies, and capillary electrophoresis has recently been shown to provide useful data [41, 42] 
in fingerprinting experiments.
The remarkable diversity of instrumental approaches used in metabolic fingerprinting 
experiments is traceable in large part to the flexibility of the multivariate analysis techniques 
used to analyze the collected data. A data matrix X, containing N observation row vectors of 
K variables each, is almost universally common [34, 43, 44], and very few mathematical 
constraints are placed on the values it holds. Correspondingly, NMR, MS, FT-IR, or any 
other source of spectral data can be used as input into the data matrix X. However, as 
discussed below, preprocessing of the data matrix is essential to yield interpretable results. 
This data matrix X can be immediately decomposed using unsupervised dimensionality 
reduction methods, such as PCA, or it can be paired with a matrix Y of N corresponding M- 
dimensional outputs for use in supervised dimensionality reduction, in the case of PLS 
regression (PLSR) and its descendants. An output may range from a simple class 
membership designation [35] to a range of observables [45], such as patient histories (age, 
sex, weight, etc.). While the same mathematical flexibility also applies to outputs, metabolic 
fingerprinting data typically stores binary (or n -ary) class membership information in Y, in 
which case the applicable supervised methods are forms of discriminant analysis (PLS-DA, 
OPLS-DA). A graphical representation of the data (X) and response (Y) matrices, along with 
their PCA/PLS decomposition, is shown in Figure 1.
Simply, the primary goal of PCA and PLS is to identify class differences from a multivariate 
dataset. A class can refer to any biologically relevant classification, such as humans treated 
with a specific diet or drug; or cells exposed to particular environmental stress (temperature, 
pH, osmolality, etc.), or different genetic modification to an organism. An NMR, MS, or FT-
IR spectrum of a biofluid or metabolome extract is an observation: a vector of K variables, 
where each spectrum represents an individual cell culture, tumor or organism. The entire 
collection of N observations forms the data matrix X. PCA and PLS then identify a 
combination of the K variables or spectral features that defines the class separation.
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A key characteristic of metabolic fingerprinting datasets is an excess of observed variables 
(K) in comparison to the number of observations (N), belonging to the so-called ‘large K, 
small N’ class of problems in statistics [46]. This feature makes traditional linear regression 
methods infeasible, as X is no longer invertible (i.e. it is singular) and no unique least-
squares solution exists. Consequently, analysis of metabolomics data requires the use of 
multivariate analysis methods capable of dealing with significant amounts of collinearity in 
X, of which PCA and PLS are prime examples.
Linear transformations
The ultimate goal of the multivariate dimensionality reduction algorithms discussed herein is 
to find a K -by- P matrix A that optimally transforms the data matrix X into a new matrix of 
P -dimensional scores given by T:
[1]
Thus, each row of T is a transformation of the corresponding row of X. Alternately, 
expressing the i -th row of X as a column vector xi and the corresponding row of T as a 
column vector ti shows that the so-called ‘weights’ matrix AT defines a linear transformation 
from the input data space occupied by X to the output space of T, termed the ‘scores’ space:
[2]
In the case where P is less than K, the dimensionality of the scores space will be less than 
that of the input data space and the above transformation has achieved dimensionality 
reduction. This is a key characteristic of multivariate analysis in metabolic fingerprinting. 
Finally, the optimal transformation by matrix A depends on the chosen algorithm, such as 
PCA, PLS, or OPLS.
Principal Component Analysis
Principal component analysis (PCA) is arguably the most widely used multivariate analysis 
method for metabolic fingerprinting and, in fact, chemometrics in general. The objective of 
PCA is to arrive at a linear transformation that preserves as much of the variance in the 
original data as possible in the lower dimensionality output data [44]. It can be shown [44] 
that the transformation A that achieves this objective is a matrix whose columns are the first 
P eigenvectors of the non-singular portion of the sample covariance matrix S:
[3]
Here, H is the N -by- N centering matrix used to center each variable about its sample mean. 
The second equality above describes the form of the eigendecomposition of S, where Q is 
the matrix of eigenvectors of S and Λ is a diagonal matrix of the corresponding eigenvalues. 
When X is left unscaled, the eigenvalues in Λ equal the variances of the newly transformed 
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data in T, providing a means to calculate the ratio of variance preserved during the 
transformation relative to the original variance:
[4]
Where  is the amount of variance in X preserved in the i -th principal component. Given 
the fact that Λii decreases monotonically with i, it can be seen that each principal component 
preserves progressively less variance of the original data.
Partial Least Squares
While the unsupervised nature of the PCA algorithm provides a means to achieve unbiased 
dimensionality reduction, its application only reveals group structure when within-group 
variation is sufficiently less than between-group variation. Therefore, supervised forms of 
discriminant analysis such as Partial Least Squares (PLS-DA; alternatively Partial Least 
Squares Projections to Latent Structures [35]) that rely on the class membership of each 
observation are also commonly applied in metabolic fingerprinting experiments [35, 47]. 
When class memberships are coded in matrix form into Y [47] and the PLS components are 
constrained to be orthogonal, the dimensionality-reducing transformation A is a matrix 
whose columns are the first P eigenvectors of a matrix formed by the covariances between X 
and Y:
[5]
Where H is again the centering matrix and the eigendecomposition takes an identical form 
to that shown for PCA. Thus, the new ‘latent variables’ formed by this transformation are 
linear combinations of original variables that preserve as much covariance between X and Y 
as possible in the first transformed dimensions; simply put, the low-dimensional scores 
space is formed predominately by the predictive components of X. This casting of PLS-DA 
as an eigendecomposition problem [48] is of course, complementary to the usual description 
of the algorithm as an iterative regression problem that more closely resembles the roots of 
PLS regression [34, 35]. However, it provides a means to contrast the results of PLS-DA 
with those of PCA. In fact, placing every observation into its own class, effectively setting Y 
to the identity, yields an identical eigenvector problem to that of PCA.
It is far more common, however, to find descriptions of PLS-DA that do not impose 
orthogonality of the PLS components; these methods require instead that the X scores be 
uncorrelated, closer to traditional PLS regression [35]. The popular form of PLS-DA under 
this condition is then:
[6]
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[7]
Where T and P are the scores and loadings for X, U and C are the scores and loadings for Y, 
and E and G are the residual errors of X and Y that are left unaccounted for in the model. 
Decomposition is performed such that T and U share maximum covariance, in effect 
allowing T to serve as an estimator of U. These equations emphasize the fact that PLS finds 
a small set of scores and loadings – the latent structures – which most effectively summarize 
X and Y as well as describe their correlation. Until recently, this traditional PLS regression 
method was referred to as Partial Least Squares due to its use of Non-linear Iterative Partial 
Least Squares (NIPALS) for estimating model parameters. With the introduction of PLS to 
chemometrics, an alternative meaning of ‘Projection to Latent Structures’ has also been used 
for the methods of Partial Least Squares regression [35].
Orthogonal Projection to Latent Structures
The utilization of class memberships in PLS-DA allows the algorithm to better expose 
separations between classes in scores space. However, variation not directly correlated with 
Y is still present in the scores. This complicates interpretation of PLS-DA scores and 
loadings plots, especially as the number of classes increases [43]. Orthogonal Projections to 
Latent Structures (OPLS) addresses this interpretability problem by incorporating an 
Orthogonal Signal Correction (OSC) filter [49-51] into a PLS model, effectively separating 
Y -predictive variation from Y -uncorrelated variation in X:
[8]
Where To and Po are the scores and loadings, respectively, for the Y -uncorrelated variation 
identified by the OSC filter. The predictive OPLS-DA scores and loadings used to estimate 
Y are then composed of variation directly correlated with Y and free of interfering structured 
variation, yielding enhanced interpretability when compared with PLS-DA [43, 52]. Finally, 
it is important to note that OPLS-DA provides no predictive advantage over PLS-DA [53]; 
in fact, when no Y -uncorrelated variation exists in X, OPLS-DA will yield an identical 
model to PLS-DA.
Method Selection
In designing experiments for metabolic fingerprinting studies, the choice of multivariate 
analysis method must be driven by the data and the experimental goals. For exploratory 
studies where metabolomic differences between experimental groups may be unknown or 
unpredictable, initial application of PCA provides an informative first look at the dataset 
structure and relationships between groups. Even when dataset structure may be predictable, 
initial use of unbiased methods like PCA provide further confirmation prior to analysis by 
supervised methods. Ideally, the results of PCA analyses would be used to formulate an 
initial biological conclusion, which PLS or OPLS can then verify and test in more detail. 
The principal reason for this is due to the fact that separation is only observed between 
groups in PCA scores when within-group variation is significantly less than between-group 
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variation in the data, while separation in PLS scores may simply be fortuitous. Therefore, 
PLS classification guided by well-separated PCA scores has a greater likelihood of 
producing biologically relevant results.
Data Preprocessing
Pre-treatment of raw spectral data is critical for generating reliable, interpretable models 
using multivariate analysis techniques. A summarization of the procedures involved for 
preprocessing of metabolic fingerprinting datasets has been well described, and efforts have 
been made to standardize the processes [54, 55]. Nevertheless, depending on the 
instrumental technique, the experimenter must adopt certain procedures to obtain an optimal 
model.
Binning and alignment
As 1H NMR chemical shifts vary at times with a strong dependence on temperature, pH, 
ionic strength, and other factors that influence their electronic environment, metabolic 
fingerprinting datasets acquired from NMR spectrometers suffer from imprecisions in 
chemical shifts, and thus in the X variables. Therefore, models generated using PCA or PLS-
DA on full-resolution 1H NMR spectra may fail to identify separations between classes, and 
their loadings can be difficult to interpret due to the over-abundance of variables. These 
complications from chemical shift variations may be mitigated by uniformly dividing each 
spectrum into ‘bins’ having typical spectral widths of 0.04 ppm and integrating signal 
intensities within each bin to produce a smaller set of variables. A representative example of 
a binned 1H NMR spectrum is given in Figure 2, showing the appreciable loss of resolution 
typically incurred.
The binning procedure not only masks subtle chemical shift differences and filters noise in 
spectra, but it also hides potentially significant changes of low-intensity peaks nearby strong 
signals. Unfortunately, uniform binning incurs the risk of splitting peaks or spectral features 
between bins, recreating the imprecision in the X variables that the preprocessing set out to 
correct. “Intelligent” or “adaptive” binning endeavors to evade this problem by using 
variable bin sizes that avoid dividing peaks between multiple bins [56-59]. A recent kernel-
based method of binning seeks to optimally reduce variable count while retaining spectral 
information by applying a Gaussian weighting function [57]. Other adaptive binning 
methods rely on a recursive algorithm [56], undecimated wavelet transforms [58] or the 
optimization of an objective function using a dynamic programming strategy [59] to identify 
bin edges. Regardless of the approach, adaptive binning performs significantly better than 
uniform binning [59]. Alternatively, full-resolution spectral signals may be computationally 
aligned within a dataset to remove chemical shift variability, retaining the possibility of 
avoiding binning and performing multivariate analysis with less loss of spectral information 
[60-65]. Spectral alignment has been accomplished using a variety of approaches that 
includes fuzzy warping, genetic algorithms, a generalized fuzzy Hough transform approach, 
a reduced set mapping (PARS) algorithm, or a recursive segment-wise peak alignment. 
Importantly, spectral alignment was shown to improve upon the results obtained using 
adaptive binning [65]. Sample acidification has also been used prior to data collection to 
force peaks into alignment [66]. Finally, it has been demonstrated that OPLS-DA more 
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effectively copes with chemical shift variation in full-resolution 1H NMR datasets [67] 
without requiring binning or alignment steps.
A similar alignment problem arises in the retention times of chromatograms used in GC-MS 
and LC-MS metabolomics experiments, where shifts in observed metabolite retention times 
between samples can obscure true relationships in model loadings [68]. The use of 
correlation optimized warping (COW), a specialized form of dynamic time warping (DTW), 
has recently found success in bringing peaks in chromatographic datasets into alignment by 
means of a dynamic programming algorithm [69, 70]. Methods of automated optimal 
parameter selection for COW have also been introduced, reducing the amount of operator 
intervention required for aligning large datasets [71]. Maven [72], MetaboAnalyst [73], 
MZmine [74] and PolyAlign [75] are just a few examples of some popular alignment 
software programs and metabolomics work-flow packages that are available. Some recent 
alternatives to COW approach to peak alignment include model-base [76], density 
maximization [77], fuzzy clustering [78] or maximum-likelihood [79].
Data normalization
To account for variable dilution factors of metabolic fingerprinting samples arising from 
variations in the number of cells, biofluid volume or tissue size, each observation row in X 
may be normalized to ensure that all observations are directly comparable. Normalization 
may be accomplished internally by computational means using internal standards (e.g. 
TMSP in NMR) [80, 81] or externally via measurements of cell culture optical density or 
protein content. The simplest form of internal scaling, called constant-sum normalization, is 
where each spectrum is normalized such that its integral is 1. While this accounts for 
variable dilutions each sample may possess, it can mask truly biologically relevant changes 
and obscure interpretation of loadings [80].
Data scaling
While the discussed forms of multivariate analysis are defined based on the covariance 
eigenstructure of X and Y, practical considerations motivate the use of variable scaling prior 
to analysis. From an intuitive standpoint, a linear combination of observations from different 
instrumental sources – 1H NMR and MS, for example – has no physical meaning. However, 
even when all variables bear identical units, highly disparate intensities and variances 
between variables will force most forms of multivariate analysis to focus on a small set of 
intense signals [44]. For these reasons, variables may be autoscaled to have zero mean and 
unit variance through a z -scoring operation [80] that results in PCA and PLS examining 
correlations, rather than covariances, in X and Y. Myriad other forms of scaling exist (Table 
1), each of which enhance different features in the data and carry different disadvantages, 
which may suit every metabolic profiling experiment differently [82]. Figure 3 shows the 
results of applying unit variance autoscaling to a set of simulated two-peak NMR spectra.
Noise and baseline removal
A principal disadvantage of data scaling is its tendency to amplify instrumental noise, to 
which PCA and PLS have been shown to be sensitive [52, 83]. Methods of scaling based on 
Maximum Likelihood PCA (MLPCA) [84] have been used to estimate and remove 
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instrumental errors prior to multivariate analysis [85]. More simply, domain knowledge may 
be used to preselect variables based on experimental relevance or noise criteria for the 
removal of signal-free baseline noise from acquired spectra or the selection of more narrow 
spectral regions [86].
Variable selection
Due to the expense of sampling and data collection in metabolomics experiments, a 
tendency exists in metabolic fingerprinting studies to retain all collected variables for 
multivariate analysis [86]. Unfortunately, this exacerbates the aforementioned collinearity 
problem and increases the likelihood of finding spurious correlations in data, leading to a 
greater chance of inferring incorrect biological conclusions [46, 51]. While it is not typically 
performed during data exploration, variable selection may be used conservatively in concert 
with domain knowledge to select only biologically meaningful regions of datasets for 
classification or dimensionality reduction. 1H NMR datasets, for instance, may contain 
highly varying signals from solvents, buffers and chemical shift reference compounds, as 
well as large signal-free noise regions. Both of these features may obscure biologically 
relevant variation and are good candidates for variable selection/removal. Structured noise 
(baseline issues, contaminants) negatively affects the correspondence between scores and 
loadings and hinders the correct interpretation of PLS results [87]. OPLS can separate out 
this structured noise, but often at the expense of an overly complex model [88]. There are 
significantly more variables (K) than observations (N) in a typical metabolomics dataset, so 
removing irrelevant variables is beneficial to the multivariate analysis. A more exhaustive 
variable selection approach applies a pretreatment based on orthogonal projections [89] or a 
recursive algorithm [90-92], support vector machine, genetic algorithm or random forest, to 
select for variables or spectral features primarily contributing to class separation. This is 
particularly pertinent to MS metabolomics data that may contain a very large number of 
variables, of which only a small percentage is relevant. Importantly, either the complete 
absence of variable selection or an overly aggressive variable selection may lead to 
inadequate separation or over-fitting of the dataset, respectively [92, 93].
Interpretation
Interpretation of multivariate analysis results of metabolic fingerprinting data for the 
purposes of inferring biological importance must be done with care, bearing in mind the 
nature and goal of the algorithm used. Scatter plots of scores and loadings are no exception, 
particularly since different axis scaling can produce misleading results [86, 94]. As an 
illustration, an observed difference in a scores plot comparing spectral data obtained from 
healthy and ill patients may infer the existence of potential disease biomarkers. Thus, it is 
imperative to verify that this variation is due to an underlying biological source instead of 
artifacts induced by the algorithm, sample handling or data processing.
Scores
Scores produced by PCA and PLS are the observation rows of X projected onto a hyperplane 
within the data that describes the covariances of X, or the covariances between X and Y, 
respectively. In a nutshell, scores are good ‘summaries’ of the observations [35]. Because 
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fewer predictive components are required to yield discrimination in OPLS-DA, two-class 
scores plots are commonly built from one predictive component and one orthogonal 
component. For PCA, class separations in scores are exposed only when within-class 
variation is less than between-class variation. Because of this, misleading class separation in 
a PCA scores plot is not a function of the algorithm, but occurs from sample preparation 
problems [95], experimental bias [96], or inappropriate data preprocessing [82]. Contrary to 
PCA, PLS and OPLS aggressively over-fit models to the data, almost always yielding scores 
in which classes are separated [88]. As a result, PLS and OPLS can generate excellent class 
separation even with random data (Figure 4) [86]. Thus, extreme care must be taken not to 
infer model reliability from the existence of class separations in PLS or OPLS scores. In 
effect, the use of PLS or OPLS models necessitates validation [97].
For PCA and validated PLS scores, quantitative measures must be applied to reliably infer 
significant separations between classes within a scores plot [98]. Simply, a visual inspection 
of the clustering pattern or class separation in a scores plot is not typically sufficient to infer 
statistical relevance. Methods using cluster overlap metrics [99], statistical distances [98], 
and hierarchical clustering [100, 101] have been successfully used to quantify separations in 
scores plots. Also, class membership may be inferred from 95% confidence ellipses 
calculated from scores [101].
Loadings
Loadings from PCA and (O)PLS are the directions of the hyperplane mentioned above with 
respect to the original X variables, and function as good ‘summaries’ of the variables' 
influence on the model. Due to the complementary nature of scores and loadings as 
explanations of the rows and columns of X, respectively, the two may be used in concert. 
Variables whose loadings are co-located away from the origin in a loadings plot may be 
inferred to be correlated. Moreover, variables with loadings in a given position in a loadings 
plot contribute heavily to observations whose scores are found in a similar position in a 
scores plot. This requires proper normalization such that the scores and loadings are on the 
same scale, where the loadings closest to the scores are expected to have the highest 
contribution to class separation. The ease of interpretation of loadings is directly affected by 
the number of variables and the scaling method used, if any [82]. As indicated by Table 1, 
scaling protocols emphasize different spectral features which will then perturb the influence 
of a particular variable on the model. In turn, the magnitude of the corresponding loadings 
will be proportionally affected. As an example, Pareto scaling is commonly used to reduce 
the influence of intense peaks while emphasizing weaker peaks that may have more 
biological relevance. The corresponding loadings of intense peaks will be reduced and 
loadings from weak peaks will be increased due to Pareto scaling.
Loadings may also be examined on a per-component basis as a line plot, with the loading 
value plotted as dependent upon the spectral variables (ppm, m/z, v). This is especially 
valuable when full-resolution spectra are used as data. In this form, the loadings of each 
model component may be viewed as a spectrum or pseudo-spectrum, with large positive or 
negative excursions of a variable's loading corresponding to a large positive or negative 
correlation with class structure, respectively. With full-resolution spectra and OPLS-DA 
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models, this method of interpreting loadings is highly useful for identifying metabolites 
contributing to class differences [67, 102]. Pareto scaling has an added advantage in this 
context, as it better preserves spectral lineshapes in loading pseudo-spectra. Of course, large 
loadings corresponding to irrelevant spectral regions such as noise, artifacts, buffers, or 
solvent peaks, raise serious concerns about the biological relevance of the model.
Weights
The weights produced in A by multivariate analysis are the relative degrees of influence that 
each observed variable in X has on each of the latent structures in the model, and are used to 
transform new observation vectors from later measurements into scores space for the 
purposes of class prediction. A common misconception is misrepresenting loadings as 
weights for the purposes of identifying variable or metabolite contribution to class 
separation.
Validation
PLS and OPLS have an innate tendency to over-fit models to data, even identifying 
excellent class separation in completely random variables as demonstrated in Figure 4 [88]. 
For PLS and OPLS, validation is a critical step in ensuring model reliability. Truly honest 
model validation requires partitioning the data into a training set used to build a model and a 
validation set used to assess predictive ability of the model, where the validation set is in no 
way used to generate the trained model [103, 104]. Few practitioners have adopted this 
method of validation because of the low sample count in metabolic fingerprinting 
experiments and the costly nature of sample preparation and data acquisition. Instead, 
internal cross-validation is routinely employed, where the leave-one-out method is a 
common choice [105]. However, it has been demonstrated that leave-one-out internal cross-
validation should be abandoned [106-108] in favor of the more consistent leave- n -out 
method.
In the leave- n -out method, the data is partitioned into  subsets, where each of the 
subsets is then used as a validation set [109, 110]. As true leave- n -out cross-validation is 
computationally inefficient, Monte Carlo cross-validation may be utilized to rapidly estimate 
model prediction ability [111, 112]. The quality assessment (Q2) statistic is typically 
reported as a result of cross-validation and provides a qualitative measure of consistency 
between the predicted and original data. Even still, Q2 has no standard of comparison or 
critical value for inferring significance, aside from its theoretical maximum of 1 or an 
empirically inferred acceptable value of ≥ 0.4 for a biological model [88]. Unfortunately, an 
invalid or irrelevant model is still capable of producing a large Q2 value, since consistent 
cross-validation requires a systematic deletion of large portions of its dataset during training. 
One solution recently demonstrated for metabolomics combines random permutation of 
class labels, which requires no deletion of data, with internal leave- n -out cross-validation 
[88]. The approach produces a distribution of Q2 values suitable for testing the null 
hypothesis for a model's Q2. In essence, a reliable model should yield a significantly larger 
Q2 value compared to Q2 values generated from random models using the same data set. 
The technique is also valid for testing null hypotheses for the area under Receiver Operating 
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Characteristic (ROC) curves (AUROC) statistic and misclassification count. Another 
method, the CV-ANOVA, uses the cross-validated predictive residuals of a model as a basis 
for hypothesis testing [97].
Also, while they are not strictly a cross validation measure, the R2 values of a given model 
may be used to assess its degree of fit to the data [35, 44]. PCA decompositions will return 
only R2X, the degree to which the principal components describe the observation data, and 
PLS decompositions will return both R2X and R2Y. Due to its division of X into Xˆ and Xˆo, 
OPLS splits R2X into R2Xp and R2Xo, the explained sum of squares of the Y -predictive and 
Y -uncorrelated components of X, respectively. Highly disparate R2 and Q2 values (i.e. R2, 
Q2) are an indicator of possible model over-fitting in supervised analyses.
Applications
Raman and NMR Fingerprinting of Rat Urine
The application of Raman spectroscopy to the study of metabolite fingerprints has occurred 
only relatively recently compared with the more mature NMR and MS techniques [31]. A 
comparative analysis demonstrates Raman spectroscopy offers complementary spectral 
information to NMR [40]. In the study, three groups of rats were orally fed different triazole 
fungicides, and a fourth group was fed only the drug carrier vehicle as a control. After five 
days of exposure, urine was collected from the rats and subjected to both 1H NMR and 
Raman spectroscopy. NMR spectra were acquired on a Varian Inova 800 spectrometer with 
a spectral width of 12.5 ppm over 64k data points using a standard 1D pre-saturation pulse 
sequence. Peaks corresponding to the solvent, urea and carrier vehicle were removed from 
the spectra, which were then truncated to 0.5 – 9.5 ppm extents and integrated into 0.04 
ppm-wide bins. The NMR bins were then mean-centered and Pareto scaled [82] prior to 
PCA.
While collection and PCA of Raman spectra was performed in similar fashion to the NMR 
data, several marked differences exist. First, samples for Raman analysis were subjected to 
ultrafiltration to remove fluorescent biomacromolecules having molecular weights greater 
than 500 Da. While the filtration step reduced biologically irrelevant chemical noise in the 
collected spectra, the authors noted that the tricarboxylates citrate, trans-aconintate, and 
oxoglutarate were significantly removed in the process. Raman spectra were then collected 
with 785 nm laser excitation at ∼5 cm-1 resolution between ∼3280 – 95 cm-1. Unlike the 
collected NMR spectra, Raman peaks showed no significant pH-dependent variation, 
permitting the full spectral resolution to be used in PCA without binning or alignment. 
Spectra of urea and sodium azide were subtracted from each spectrum, which were then 
truncated to 1705 – 467 cm-1, mean-subtracted, normalized to constant AUC and submitted 
to PCA and PLS-DA.
Figure 5 shows a comparison of the PCA scores produced by the collected NMR and Raman 
datasets. From the scores, it can be seen that the within-class variation of the Raman spectra 
is noticeably lower than that of the NMR spectra, effectively showing a better separation for 
the collected samples. However, due to the low number of spectra collected for each 
experimental class, it is difficult to judge class separations on a statistical basis. The authors 
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note that PCA captured a greater percentage variance of the Raman spectra than the NMR 
spectra, suggesting better performance. This use of captured variance is incorrect, however, 
as captured variance is a relative measure that only describes model performance for any 
given dataset and not between different datasets.
Finally, two-class PLS-DA was used to find loadings in the Raman spectra that 
discriminated between each fungicide treatment and the control. Significant changes in the 
loadings were found to coincide with transitions of the metabolites allantoin, creatine, 
alanine, taurine, acetate and hippurate. However, no measures of validation were provided to 
lend statistical credence to the observed metabolite changes. The class distinction present in 
the PCA scores plot does suggest the same class separation in the PLS-DA is likely correct. 
But, the PLS-DA model could still be over-fitted to the data, leading to an invalid model and 
incorrect loadings. As a result, the identified metabolites could be biologically irrelevant. 
This is not necessarily true, but it is plausible outcome in the absence of a validated PLS-DA 
model. Nevertheless, the study does provide an illustrative proof-of-principle for Raman 
spectroscopy-based metabolic fingerprinting which, with further tuning, promises to be a 
useful instrumental platform for metabolomics.
Discrimination of French Labeled Brandies
While the metabolite profiles of many brandies were previously known, marker metabolites 
that could be used to discriminate between different types of brandy were not identified. 
Such metabolites could be used in determination of the origin and authenticity of French 
labeled brandies. To that end, gas chromatography mass spectrometry (GC-MS) analyses of 
Cognac, Armagnac, Calvados and Mirabelle were analyzed and subjected to PLS-DA [113]. 
Ethyl undecanoate and 4-methylpentan-2-ol were added to the brandy samples for use as 
internal standards, and two liquid-liquid extractions were used to isolate the volatile organic 
molecules from the samples.
Peaks in the collected GC-MS spectra having a signal-to-noise greater than 10 were linked 
with compounds using database searches based on electron impact spectra and retention 
indices; the resulting intensities of all compounds were then normalized to the internal 
standards. The data matrix was then generated using the calculated relative compound 
concentrations, which were mean-centered and autoscaled to unit variance prior to PLS-DA. 
This particular study highlights the flexibility of multivariate analysis methods to accept any 
type of variable, not only raw spectral information, for modeling purposes in metabolomics.
Figure 6 shows the variable loadings from PLS-DA plotted for the two discriminatory 
components found in the GC-MS dataset. The authors understandably described the loadings 
as weights in the manuscript, a confusing description exacerbated by the SIMCA 
(UMETRICS) nomenclature for PLS loadings (w*C[n]). Unfortunately, the SIMCA 
loadings nomenclature appears startlingly similar to the PLS regression coefficients [35], the 
product of X -weights and Y -weights, and not the loadings. However, in PLS loading plots 
of this type, the X -weights (w*) and Y -weights (C) are simply plotted together – not 
multiplied – in order to expose the correlation structure between X and Y. The loadings for 
each type of brandy in scores space were printed on the loadings plot to aid in identifying 
compounds that contribute most to the discrimination between each of the beverage types. 
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Importantly, loadings must be non-zero along any principal component axis to have any 
contribution to the model.
Each loading is correlated to a particular X -variable, in this case the molecular-weight of a 
particular metabolite. Thus, the loadings strongly correlated with scores for each type of 
brandy identify metabolites that may uniquely describe or characterize that particular 
brandy. While the volatile compound identification and quantification procedure resulted in 
a great wealth of useful information, no validation statistics were provided to justify the 
discriminatory compounds selected from the PLS-DA loadings. Again, the lack of 
appropriate validation is a common problem among the metabolomics community.
Correlations of Human Gut Microbiome with Urine Metabolites
Studies have shown that the microbiome – the sum total of all microbial organisms – of the 
human gastrointestinal tract has a great impact on individual metabolite profiles, even when 
genetic variations are minimized [114]. Changes in the symbiotic gut microbes correlate 
with phenotypic variations observed between gender and across ethnicities, and are 
implicated in many forms of human pathology. Recent work based on the gut microbiomes 
and urine metabolic fingerprints of Chinese family members has shed light onto correlations 
between gut flora and phenotype [45].
In the study by Li et al., selected portions of the bacterial genomes of family members' gut 
microbiota were subjected to denaturing gradient gel electrophoresis (DGGE), and urine 
samples were also collected from each family member and analyzed by 1H NMR 
spectroscopy. OPLS-DA was used to identify gender-predictive components of the DGGE 
gels and NMR spectra. The Q2 value of each variable obtained by five-fold internal cross-
validation was used to identify statistically reliable loadings in the OPLS-DA models. 
Species of Clostridia, Bacteroidetes and Proteobacteria were found to be predictive of 
gender based on DGGE gels, and 3-aminoisobutyrate and creatine were found to predict 
gender from the NMR spectra.
A cross-correlation analysis was also performed to model the DGGE gel bands using NMR 
spectral data, and vice versa, using OPLS regression. Again, five-fold internal cross-
validation was performed to ensure model reliability, and the predictions of NMR peaks and 
DGGE bands made by the model were color-coded according to Q2 to facilitate rapid 
identification of significant correlations. A correlation matrix was also constructed to show 
peaks in the collected NMR spectra that co-varied with bands in the DGGE gel. Figure 7 
summarizes the results of the cross-correlation analysis. This study highlights a powerful use 
of OPLS, both in discrimination and regression applications, as well as the use of cross-
validation statistics.
Analysis of Bacterial Metabolic Signaling of Stress Response
It has been shown that the stress response of prokaryotic organisms contains a metabolic 
sensing component, centered around the tricarboxylic acid (TCA) cycle and sensed by 
catabolite control protein A (CcpA), that effects downstream signaling networks involved in 
virulence factor presentation and biofilm formation [115]. Metabolic fingerprinting using 1H 
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NMR spectroscopy was conducted to further examine the effects of external biofilm-
inducing perturbations on the metabolome of Staphylococcus epidermidis [116]. Metabolite 
mixtures were collected from wild-type cells, as well as cells exposed to sodium chloride, 
glucose, tetracycline, ethanol, iron-depleted media, and an aconitase deletion mutation.
PCA analysis of the NMR spectra revealed that the sodium chloride-treated cells grouped 
with the wild-type in scores space. All other observations on treated cells group together in 
scores space except for glucose treatment, which clustered separately from all observations. 
The separations between classes in the PCA scores were used to define two classes for a 
subsequent OPLS-DA analysis, with wild-type and salt-treated cells discriminated from all 
other observations. Figure 8 shows the OPLS scores plot and dendrogram resulting from 
decomposition into one Y -predictive component and three Y -uncorrelated components. In 
the OPLS model, the explained sum of squares for X and Y were found to be 0.637 and 
0.966, respectively. It is important to note that the reported R2X of 0.637 includes Y -
uncorrelated variation, and is therefore not a measure of modeled predictive variation. 
Leave- n -out internal cross-validation resulted in a Q2 value of 0.941, an acceptable value in 
light of the models R2Y, but by no means conclusive. While it was not performed for the 
publication, a subsequent validation using CV-ANOVA provided a p -value of 0.0 – to 
within machine precision [117] – for the OPLS model.
Future Directions
Multivariate analysis of metabolic fingerprinting datasets is performed most often with the 
linear projection-based methods of PCA, PLS and OPLS, but these are by no means the only 
tools available. Hierarchical clustering analysis (HCA) and nearest-neighbor clustering may 
be applied to multivariate spectral data to reveal differences between classes without 
supervision. Support-vector machine (SVM) methods [118] have been applied to human 
urine metabolomics NMR [119], NIR and UV datasets [120] with enhanced predictive 
power over PLS-DA. Artificial neural networks (ANN) have also been used in combination 
with PCA for plant metabolic profiling and fingerprinting [121, 122]. In contrast to pure 
PCA and PLS, which model linear relationships, both SVM and ANN algorithms admit the 
use of a kernel function to allow for modeling of non-linear relationships between X and Y. 
However, none of these methods provide quite the interpretative simplicity of projective 
‘latent-space’ methods such as PCA and PLS. The metabolomics community is accustomed 
to drawing conclusions from PCA and PLS results, but these new methods with their 
unfamiliar analysis formats require further acclimation.
Finally, the majority of multivariate analysis techniques used in metabolic fingerprinting are 
designed for ‘snapshot’ datasets, where the state of a system is observed at one or two highly 
distinct time points. However, as instrumental methods improve to accommodate 
measurement of highly time-resolved metabolite concentration changes, methods of 
multivariate analysis must be developed to cope with the new information [123]. Multi-way 
data analysis methods such as Parallel Factor Analysis (PARAFAC [124]), consensus PCA 
(CPCA) and multi-block PLS are all suited to particular types of multi-way datasets [125]. 
Somewhat similar in form to time-resolved metabolomic datasets are those produced by the 
fusion of data from orthogonal or complementary instrumentation. For example, 1H NMR 
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and LC-MS data matrices have been combined by multiple means to achieve improved PCA 
and PLS models [126]. GC-MS and LC-MS datasets [127], as well as near-IR and mid-IR 
spectral datasets [128] have been similarly fused for the purposes of multivariate analysis.
Concluding Remarks
Techniques such as PCA and PLS provide an essential platform for rapid interpretation of 
information-rich spectral datasets for inferring biological conclusions. Through proper 
application of preprocessing transformations, optimal choice of analysis algorithms, and 
judicious application of validation metrics, MVA can lend a powerful hand in the biological 
understanding and exploration of complex, multiparametric metabolic systems. 
Unfortunately, misunderstandings and the misuse of MVA can lead to misleading or 
erroneous biological inferences. The few examples highlighted in this review are just a 
sampling of the large number of metabolomics studies with similar problems. Additionally, 
metabolomics has many data challenges left to be solved, and machine learning 
chemometrics methods have much to offer metabolomics.
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Figure 1. 
Canonical example of the data (X) and response (Y) matrices and decompositions thereof 
used by projection-based multivariate analysis algorithms. In metabolic fingerprinting 
applications, the data matrix will contain spectral information on its rows, such that every 
column will represent a single spectral frequency or bin. For supervised projections, each 
row of data is paired with a corresponding row in the response matrix that holds either 
continuously varying outputs or binary (n -ary) class memberships. The data is then 
decomposed into a small number of score vectors (t) and loading vectors(p), with a 
corresponding weight vector (w) used to transform rows of X to scores space. Responses are 
similarly decomposed into scores (u) and loadings (C), where t is an effective estimator of u. 
Adapted with permission from reference [35], (Copyright 2001 Elsevier).
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Figure 2. 
Example of the use of binning on a 1H NMR spectrum of a rat urine sample, with a bin 
spectral width of 0.04 ppm. In this example, binning reduces the number of data variables 
from 65,536 to 312, facilitating multivariate analysis by PCA and PLS-DA. Reprinted with 
permission from reference [40], (Copyright 2007 American Chemical Society).
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Figure 3. 
Demonstration of the effects of autoscaling to unit variance in simulated 1H NMR spectral 
data. (A) Set of 40 spectra containing two Lorentzian peaks having random intensities, 
summed with Gaussian baseline noise. (B) Spectra from above with mean-centering. (C) 
Spectra with mean-centering and autoscaling to unit variance, exhibiting amplification of 
noise in signal-free regions. Adapted with permission from reference [80], (Copyright 2006 
American Chemical Society).
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Figure 4. 
Scores from the PLS-DA discrimination of 1H NMR spectra from 23 healthy volunteers, 
where class labels have been randomly assigned. Internal cross-validation produces a Q2 of 
-0.18, clearly well below acceptable limits. Nevertheless, the scores plot displays a clear 
separation between classes that could lead the inexperienced practitioner to wholly false 
biological conclusions. Reprinted with permission from reference [88], (Copyright 2008 
Westerhuis et. al.).
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Figure 5. 
Scores from PCA decomposition of (A) 1H NMR and (B) Raman spectra of rat urine 
metabolites, demonstrating the use of PCA to compare within- and between-group variation 
datasets from complementary instrumental sources. In this example, the captured variances 
on each plot reflect the relative effectiveness of PCA to approximate the input data, and may 
not be used as a standard of comparison. Reprinted with permission from reference [40], 
(Copyright 2007 American Chemical Society).
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Figure 6. 
PLS-DA loadings for volatile compound composition of French labeled brandies. Clustering 
patterns of variables reveal relevance of those X variables to the responses in Y. The Y -
weights for each type of brandy are labeled and represented as squares, and the X -weights 
are represented as numbered triangles. Variable numbers relate to volatile compounds 
identified by GC-MS analysis, with the identity and amount of each compound may be 
found in reference [113]. Reprinted with permission from reference [113], (Copyright 2010 
American Chemical Society).
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Figure 7. 
Cross-correlation analysis between the DGGE gel in (A) and collected 1H NMR spectra of 
urine metabolites. (B) Prediction of DGGE bands using NMR spectra. (C) Correlation 
matrix relating the aromatic region of collected NMR spectra to DGGE bands. Red indicates 
positive correlation greater than 0.7 and blue indicates negative correlation of the same 
magnitude or greater. (D) Prediction of the NMR spectral aromatic region based on DGGE 
data. Both predictions from OPLS regression are colored according to Q2 obtained from 
cross-validation. Reprinted with permission from reference [45], (Copyright 2008 National 
Academy of Sciences of the USA).
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Figure 8. 
Results of OPLS-DA modeling of the metabolomic effects of six different stressors on S. 
epidermidis. (A) OPLS scores of all experimental groups, showing the high observation 
counts for each group necessary for statistical treatment of scores. Ellipses around each 
group the 95% confidence regions of the groups under the assumption of normally 
distributed data. (B) Dendrogram built from OPLS scores-space data using Euclidean 
distances between the sample means of each group. Within-group substructure that was not 
forced during class discrimination is evident in the dendrogram. Group name colors in (B) 
correspond to scores colors in (A). Reprinted with permission from reference [116], 
(Copyright 2011 American Chemical Society).
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Table 1
Listing of most commonly used data scaling methods in metabolic fingerprinting multivariate analyses.1
Method Equation Goal Advantage Disadvantage
Centering
x
∼
ik = xik − x¯k
Focus on differences, not 
similarities
Removes offset from the data Unsuitable for heteroscedastic 
data
UV
x
∼
ik =
xik − x¯k
sk
Compare metabolites based 
on correlation
All metabolites equally 
important
Inflation of measurement errors
Range
x
∼
ik =
xik − x¯k
xk ,max − xk ,min
Compare metabolites relative 
to biological response range
All metabolites equally 
important. Biologically related 
scaling
Inflation of measurement errors, 
sensitive to outliers
Pareto
x
∼
ik =
xik − x¯k
sk
Reduce relative importance of 
large values, partially 
preserve data structure
Stays closer to original 
measurement than UV
Sensitive to large fold changes
Vast
x
∼
ik =
xik − x¯k
sk
C
x¯k
sk
Focus on small fluctuations Aims for robustness, uses prior 
group knowledge
Not suited for large induced 
variation without group structure
Level
x
∼
ik =
xik − x¯k
x¯k
Focus on relative response Suited for biomarker 
identification
Inflation of measurement errors
1Variable subscripts reflect conventions shown in Figure 1, with the mean of the k -th variable in X represented by x̄k and its deviation represented 
by sk, the sample standard deviation. Reprinted with permission from reference [82], (Copyright 2006 van den Berg et. al.).
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